A phase I trial of GEN 1 in patients with glioblastoma.

Trial Profile

A phase I trial of GEN 1 in patients with glioblastoma.

Planning
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2015

At a glance

  • Drugs GEN 1 (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Oct 2015 Planned initiation date changed from 1 Feb 2016 to 1 Jul 2015, as per Celsion media release.
    • 09 Sep 2015 Planned initiation date changed from 1 Dec 2015 to 1 Feb 2016, as per Celsion media release.
    • 06 Jan 2015 Celsion Corporation is still planning to initiate this trial, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top